Skip to content
Nottingham Technology Ventures
  • About us
  • Spin-out portfolio
    • Full portfolio
    • Healthcare
    • Agriculture & the environment
    • Materials & manufacturing
    • Digital
    • Exits
  • News
    • NTV news
    • Spin-out news
    • Spin-out Twitter wall
  • Contact us
Menu
  • About us
  • Spin-out portfolio
    • Full portfolio
    • Healthcare
    • Agriculture & the environment
    • Materials & manufacturing
    • Digital
    • Exits
  • News
    • NTV news
    • Spin-out news
    • Spin-out Twitter wall
  • Contact us
Search
Close

Spin Out company name: Locate Bio

Locate Bio Closes £10 million Funding Round

CognitOss Granted FDA Breakthrough Device Designation

Locate Bio appoints Keith Valentine as the Non-Executive Chair of the Board of Directors

Locate Bio acquires complementary late stage orthobiologics assets, accelerating ambition of building a world leading, diversified orthobiologics company

Locate Bio raises £2.25m for new spinal treatments

Locate Bio announces the appointment of John von Benecke as CEO

Locate Bio is granted key US and EU patents for its IntraStem™ non-viral, next generation gene delivery technology

Locate Bio

Locate Bio announces appointment of Dr Nick Staples as CEO

Locate Therapeutics announce name change to Locate Bio and new investment from Mercia Technologies PLC

© 2020 Nottingham Technology Ventures Limited.
All rights reserved.

Registered in England number 04477457
Registered office address

University Of Nottingham Kings Meadow Campus, Lenton Lane, Nottingham, England, NG7 2NR

Privacy Policy | Terms & Conditions | Cookies
Website by Clifton Media

Nottingham Technology Ventures Limited
The Ingenuity Centre
University of Nottingham Innovation Park
Triumph Road
Nottingham
NG7 2TU

  • [email protected]
  • +44 (0)115 823 2180
  • Download Annual Report (pdf)